Agape ATP Corporation (NASDAQ:ATPC - Get Free Report) traded up 2.7% during mid-day trading on Wednesday . The company traded as high as $1.47 and last traded at $1.43. 41,652 shares changed hands during trading, a decline of 98% from the average session volume of 1,762,955 shares. The stock had previously closed at $1.39.
Analysts Set New Price Targets
Separately, Wall Street Zen raised Agape ATP from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd.
Read Our Latest Stock Report on Agape ATP
Agape ATP Trading Up 5.5%
The company has a market capitalization of $74.41 million, a PE ratio of -2.48 and a beta of -0.98. The stock has a fifty day simple moving average of $1.63 and a 200-day simple moving average of $1.45.
Agape ATP (NASDAQ:ATPC - Get Free Report) last announced its quarterly earnings results on Thursday, May 15th. The company reported ($0.07) earnings per share (EPS) for the quarter. Agape ATP had a negative return on equity of 30.95% and a negative net margin of 191.34%.
Agape ATP Company Profile
(
Get Free Report)
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names.
Featured Stories
Before you consider Agape ATP, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agape ATP wasn't on the list.
While Agape ATP currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.